[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:amphetamine-induced-organic-mental-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":142,"states":143},"Amphetamine-induced organic mental disorder",21,14,[8,16,22,29,35,41,47,53,59,65,71,77,83,89,95,102,108,114,121,128,136],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06721494","A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine",[12],"Phase 2","RECRUITING","2026-08-26T02:17:40.683658Z","2026-07-19T19:36:05.036200Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07204249","Glutide for Ending Methamphetamine",[12],"2026-08-26T02:18:45.196599Z","2026-06-04T01:30:07.896743Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06899594","Psilocybin for Methamphetamine Addiction",[26],"Early Phase 1","2026-08-26T02:17:13.277148Z","2026-05-05T02:43:29.670419Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06320366","Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder",[],"2026-08-26T02:18:54.586325Z","2026-05-05T02:43:29.483663Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06323837","Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment",[12],"2026-08-26T02:18:14.396999Z","2026-05-05T02:43:29.347628Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06578429","Deep TMS of Neural Circuits Associated With Stimulant Use Disorder",[],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:28.406566Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06496750","Ketamine for Methamphetamine Use Disorder",[12],"2026-08-03T03:47:26.883006Z","2026-05-05T02:43:28.191159Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT06830980","Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH",[],"2026-08-03T02:48:35.792843Z","2026-05-05T02:43:26.977484Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT06532370","Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii",[],"2026-08-26T02:17:43.321968Z","2026-05-05T02:35:31.907208Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT07086014","Methamphetamine Cue-reactivity",[],"2026-08-26T02:19:25.538428Z","2026-05-13T02:55:06.650956Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT07226596","Non-Abstinence Outcomes in Methamphetamine Use Disorder",[],"2026-08-26T02:18:41.390601Z","2026-05-05T02:43:29.164252Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT06989853","Methamphetamine and Troriluzole",[26],"2026-08-26T02:15:40.343619Z","2026-05-05T02:43:28.819952Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT06712446","A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder",[],"2026-08-26T02:17:39.048487Z","2026-05-05T02:43:27.606522Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT04927143","Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives",[],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:26.936484Z",{"nct_id":96,"title":97,"phases":98,"status":99,"updated_at":100,"content_modified":101},"NCT06931197","Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization",[],"NOT_YET_RECRUITING","2026-08-26T02:17:53.433613Z","2026-05-05T02:35:31.635470Z",{"nct_id":103,"title":104,"phases":105,"status":99,"updated_at":106,"content_modified":107},"NCT07213258","CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM",[],"2026-08-26T02:17:36.611194Z","2026-05-05T02:47:14.270014Z",{"nct_id":109,"title":110,"phases":111,"status":99,"updated_at":112,"content_modified":113},"NCT07211724","Methamphetamine Use Disorder Support in Heart Failure Pilot Study",[],"2026-08-26T02:18:35.425468Z","2026-05-05T02:43:28.339897Z",{"nct_id":115,"title":116,"phases":117,"status":118,"updated_at":119,"content_modified":120},"NCT07221396","LDART for Stimulant Use Disorder",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:15.156099Z","2026-05-05T02:43:27.600329Z",{"nct_id":122,"title":123,"phases":124,"status":125,"updated_at":126,"content_modified":127},"NCT06372288","Theta Burst TMS for Treatment of Methamphetamine Use Disorder",[],"UNKNOWN","2026-08-03T02:28:08.200434Z","2026-05-05T02:43:27.600319Z",{"nct_id":129,"title":130,"phases":131,"status":133,"updated_at":134,"content_modified":135},"NCT06233799","Trial of Naltrexone\u002FBupropion for the Treatment of Methamphetamine Use Disorder",[132],"Phase 3","ACTIVE_NOT_RECRUITING","2026-08-03T03:26:55.873278Z","2026-05-05T02:35:31.912984Z",{"nct_id":137,"title":138,"phases":139,"status":125,"updated_at":140,"content_modified":141},"NCT03470480","rTMS for Craving in Methamphetamine Use Disorder",[],"2026-08-03T02:00:40.724107Z","2026-04-29T02:57:57.149526Z",[],[144,148,152],{"state":145,"count":146,"slug":147},"California",7,"california",{"state":149,"count":150,"slug":151},"Kentucky",3,"kentucky",{"state":153,"count":150,"slug":154},"Texas","texas"]